Novel avenues of tau research

Claire E. Sexton, Gal Bitan, Kathryn R. Bowles, Miroslaw Brys, Luc Buée, Mahmoud Bukar Maina, Claire D. Clelland, Ann D. Cohen, John F. Crary, Jeffrey L. Dage, Kristophe Diaz, Bess Frost, Li Gan, Alison M. Goate, Lawrence I. Golbe, Oskar Hansson, Celeste M. Karch, Hartmuth C. Kolb, Renaud la Joie, Suzee E. LeeDiana Matallana, Bruce L. Miller, Chiadi U. Onyike, Yakeel T. Quiroz, Jessica E. Rexach, Jonathan D. Rohrer, Amy Rommel, Ghazaleh Sadri-Vakili, Suzanne E. Schindler, Julie A. Schneider, Reisa A. Sperling, Charlotte E. Teunissen, Stacie C. Weninger, Susan L. Worley, Hui Zheng, Maria C. Carrillo

Research output: Contribution to journalReview articleAcademicpeer-review

2 Citations (Scopus)

Abstract

INTRODUCTION: The pace of innovation has accelerated in virtually every area of tau research in just the past few years. METHODS: In February 2022, leading international tau experts convened to share selected highlights of this work during Tau 2022, the second international tau conference co-organized and co-sponsored by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation. RESULTS: Representing academia, industry, and the philanthropic sector, presenters joined more than 1700 registered attendees from 59 countries, spanning six continents, to share recent advances and exciting new directions in tau research. DISCUSSION: The virtual meeting provided an opportunity to foster cross-sector collaboration and partnerships as well as a forum for updating colleagues on research-advancing tools and programs that are steadily moving the field forward.
Original languageEnglish
Pages (from-to)2240-2261
Number of pages22
JournalAlzheimer s & dementia
Volume20
Issue number3
Early online date2024
DOIs
Publication statusPublished - Mar 2024

Keywords

  • biomarkers
  • tau
  • tau-PET
  • tauopathies
  • therapeutics

Cite this